Cantor Fitzgerald Issues Positive Forecast for Acadia Healthcare (NASDAQ:ACHC) Stock Price

Acadia Healthcare (NASDAQ:ACHC) had its target price upped by Cantor Fitzgerald from $30.00 to $39.00 in a research report sent to investors on Friday morning, MarketBeat Ratings reports. The firm currently has a neutral rating on the stock.

ACHC has been the subject of several other research reports. Weiss Ratings restated a “sell (d)” rating on shares of Acadia Healthcare in a research report on Wednesday, September 9th. TD Cowen upped their target price on shares of Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. Guggenheim increased their target price on shares of Acadia Healthcare from $38.00 to $39.00 and gave the company a “buy” rating in a research report on Thursday, July 30th. Raymond James Financial lowered shares of Acadia Healthcare from a “strong-buy” rating to an “outperform” rating and set a $39.00 price target on the stock. in a research note on Monday, September 28th. Finally, Leerink Partners boosted their price target on shares of Acadia Healthcare from $30.00 to $33.00 and gave the company a “market perform” rating in a research report on Wednesday, September 23rd. Eight research analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, Acadia Healthcare has an average rating of “Hold” and an average price target of $32.54.

Acadia Healthcare Stock Up 6.4%

Acadia Healthcare stock traded up $2.21 during trading on Friday, reaching $37.00. The stock had a trading volume of 4,533,735 shares, compared to its average volume of 1,614,038. Acadia Healthcare has a 52-week low of $11.43 and a 52-week high of $39.38. The business has a 50 day moving average price of $29.40 and a 200 day moving average price of $26.14. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 1.20. The stock has a market cap of $3.44 billion, a PE ratio of -2.97, a P/E/G ratio of 9.54 and a beta of 0.64.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Wednesday, November 4th. The company reported $0.60 EPS for the quarter, topping the consensus estimate of $0.46 by $0.14. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The company had revenue of $895.31 million during the quarter, compared to analysts’ expectations of $877.76 million. During the same quarter in the previous year, the business posted $0.72 EPS. The firm’s revenue was up 5.1% on a year-over-year basis. On average, analysts predict that Acadia Healthcare will post 1.59 EPS for the current year.

Institutional Investors Weigh In On Acadia Healthcare

Large investors have recently modified their holdings of the company. Allworth Financial LP purchased a new position in shares of Acadia Healthcare during the second quarter worth approximately $45,000. Global Retirement Partners LLC purchased a new stake in Acadia Healthcare in the 2nd quarter valued at $68,000. Integrated Wealth Concepts LLC purchased a new stake in Acadia Healthcare in the 2nd quarter valued at $79,000. Quantbot Technologies LP acquired a new stake in Acadia Healthcare during the 2nd quarter worth $88,000. Finally, Pinnacle Wealth Planning Services Inc. boosted its stake in Acadia Healthcare by 20.7% during the 3rd quarter. Pinnacle Wealth Planning Services Inc. now owns 3,209 shares of the company’s stock worth $88,000 after purchasing an additional 550 shares during the period.

Key Stories Impacting Acadia Healthcare

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Acadia reported third-quarter EPS of $0.60, ahead of the $0.46 consensus, and revenue of $895.3 million, above estimates and up 5.1% year over year. The company also raised its full-year guidance, with its outlook described as slightly above expectations. Article
• Positive Sentiment: Guggenheim raised its target to $41 and kept a Buy rating; RBC lifted its target from $31 to $41 and maintained Outperform. These revisions reinforce optimism about further gains. Article Article
• Neutral Sentiment: Cantor Fitzgerald raised its target to $39 but retained a Neutral rating, signaling a more cautious view than the bullish analyst calls. Analyst rating
• Negative Sentiment: Quarterly EPS was below the $0.72 reported a year earlier. Barclays raised its target to $35 but kept an Equal Weight rating; that target is below the cited current share price, suggesting limited upside in its view. Analyst rating

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services headquartered in Franklin, Tennessee. The company operates psychiatric hospitals, specialty treatment facilities and outpatient programs focused on mental health and substance use disorders.

Acadia’s services include inpatient and outpatient psychiatric care, addiction treatment, residential treatment, eating-disorder programs, and services for children and adolescents. Its facilities serve patients with a range of behavioral health conditions, including depression, anxiety, trauma-related disorders and substance use disorders.

Founded in 2005, Acadia operates primarily in the United States and also has a significant presence in the United Kingdom through its ownership of Priory, a behavioral healthcare provider.